ChromoTek products set new benchmarks for cellular research. ChromoTek develops and markets Chromobody®-based live cell assays for drug screening and target validation. Other products include immunological and bioimaging reagents such as the GFP-Trap® for the rapid pull-down of GFP fusion proteins and GFP/ RFP Booster to amplify the fluorescent signal of GFP or RFP fusion proteins. ChromoTek’s fluorescence based protein-protein interaction assay, called Fluorescence-2-Hybrid (F2H), is available as screening service for commercial customers and as off the shelf kit for academic research. More than 4,500 customers from all over the world trust in ChromoTek products.
Actin Chromobody visualizes cytoskeletal microfilaments in different cell types derived from human, mouse and hamster.
Successful exit for High-Tech Gründerfonds and Bayern Kapital –
Proteintech acquires ChromoTek
400 Oser Ave Ste 1650
Hauppauge, NY 11788